An underground market for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on communication apps, according to recent findings.
Experimental Treatment Gaining Traction Via Social Media
Retatrutide, which is still in clinical trials, is being promoted by online personalities for its alleged fat-burning effects. Followers are encouraged to message these profiles privately for supplier links, while also obtaining discount codes.
Thriving Commerce on Messaging Platforms
Separately, a robust market exists on Telegram, where communities with numerous of members share comparison images, injection guides and assertions of rapid UK delivery. Sellers market the drug there before directing customers to WhatsApp for purchases.
Learning About The Experimental Drug
Retatrutide is an experimental injectable developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could help patients lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.
Healthcare Experts Express Worries
Nevertheless, physicians and chemists have warned that the distribution of what remains an unapproved drug in the United Kingdom is worrisome and could lead to users injecting substances of unknown origin.
Several experts said the popularity for the experimental drug could be linked to the rising price of licensed weight loss products such as Mounjaro.
Legal Status and Implementation
Selling the unapproved drug on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that must not be promoted or supplied for personal consumption under the British medical regulations.
Several influencers try to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still breach medicines, marketing, and consumer laws, risking penalties, legal action or imprisonment.
Service Reaction and Material Removal
According to the social media company, the service has removed problematic content and prohibited related hashtags and query recommendations. The company said it was committed to maintaining the service safe and allocating resources in strengthening enforcement strategies.
Digital Marketplace Activities
Research also found groups with up to nine thousand members selling retatrutide using Telegram's built-in search feature, which functions like a online catalog. Entering “retatrutide” instantly brings up groups with thousands of users, populated with photos of weight loss, positive reviews and detailed guides for preparing or injecting at home.
After moments of entering one group, a vendor posted contact information, where most transactions take place. The seller sent an instruction manual and promised delivery within 48 hours. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None inquired about weight, health issues or past usage.
Item Details and Costs
Inside these groups, posts show dark colored packages with postal service stickers, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at residence with sterile water, or ready-to-use injectors usually sold at £160 for 20 milligrams. When asked how long a pen should be used, vendors give contradictory answers varying between a several days to “depends on your body”.
Service Oversight and Security Measures
A spokesperson for the messaging service said it actively monitored harmful content on its platform including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Medical Expert Cautions
“Individuals are administering materials they can’t verify. Although the research behind this drug is sound, these online products may not contain what they claim,” said Jason Murphy, the director of pharmacy at a pharmacy service.
A medical professional of Asda Online Doctor connected the surge in interest to recent price rises for authorized weight-loss drugs such as Mounjaro. “With costs rising, individuals are turning to social media. But counterfeit injections are highly dangerous. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she explained.
Her staff has previously encountered patients injured by self-injection from unverified sources. “We understand the disappointment, but purchasing from Telegram or communication platforms is taking chances with your health,” said Wyllie. “These materials could be impure or improperly measured.”
Producer Statement
A spokesperson from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they said, adding that any item “falsely representing itself as a Lilly investigational product not yet authorized … may expose users to possibly serious medical dangers”.
